LAM rais­es $58M for can­cer, rare dis­ease pipeline; What do you pray for?

→ Guil­ford, CT-based LAM Ther­a­peu­tics raised a $58 mil­lion C round for its work on new drugs for can­cer and rare dis­eases. “This week’s Bert Vo­gel­stein pa­per in Sci­ence showed us that next-gen­er­a­tion se­quenc­ing and math can help us to un­der­stand can­cer,” said Jonathan Roth­berg, a LAM co-founder and the re­cip­i­ent of the Na­tion­al Medal of Tech­nol­o­gy for in­vent­ing next-gen­er­a­tion se­quenc­ing. “Se­quenc­ing cou­pled with deep learn­ing is go­ing to en­able us to cure can­cer.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.